You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for Patent: 9,795,620

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,795,620 protect, and when does it expire?

Patent 9,795,620 protects ELYXYB and is included in one NDA.

This patent has sixteen patent family members in twelve countries.

Summary for Patent: 9,795,620

Title:	Oral composition of celecoxib for treatment of pain
Abstract:	The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37.degree. C..+-.0.5.degree. C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
Inventor(s):	Baheti; Ankit (Indore, IN), Padhi; Bijay Kumar (Buguda, IN), Vakada; Supritha (Hyderabad, IN), Raghuvanshi; Rajeev Singh (Gurgaon, IN)
Assignee:	Dr. Reddy's Laboratories, Ltd. (Hyderabad, Telangana, IN)
Application Number:	15/374,951
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Delivery; Dosage form;

Drugs Protected by US Patent 9,795,620

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Scilex Hldg	ELYXYB	celecoxib	SOLUTION;ORAL	212157-001	May 5, 2020		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,795,620

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
India	2682/CHE/2015	May 28, 2015
India	6614/CHE/2015	Dec 10, 2015

International Family Members for US Patent 9,795,620

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016267685	⤷ Try a Trial
Australia	2019203815	⤷ Try a Trial
Brazil	112017025445	⤷ Try a Trial
Canada	2987272	⤷ Try a Trial
China	107847437	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.